Contribution of IL-17 to mouse hepatitis virus strain 3-induced acute liver failure

[1]  Y. Chu,et al.  Critical role of interleukin‐17/interleukin‐17 receptor axis in mediating Con A‐induced hepatitis , 2012, Immunology and cell biology.

[2]  M. Cobleigh,et al.  A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. , 2011, Gastroenterology.

[3]  Xinchun Chen,et al.  Elevated IL-6 Receptor Expression on CD4+ T Cells contributes to the increased Th17 Responses in patients with Chronic Hepatitis B , 2011, Virology Journal.

[4]  Jue Wei,et al.  Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression , 2011, PloS one.

[5]  M. Zheng,et al.  T‐helper 17 cell: A distinctive cell in liver diseases , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  F. Tacke,et al.  Role of IL-17 and Th17 Cells in Liver Diseases , 2010, Clinical & developmental immunology.

[7]  Xuetao Cao,et al.  IL-17A–Producing γδT Cells Promote CTL Responses against Listeria monocytogenes Infection by Enhancing Dendritic Cell Cross-Presentation , 2010, The Journal of Immunology.

[8]  R. Gopal,et al.  IL-17 in protective immunity to intracellular pathogens , 2010, Virulence.

[9]  Q. Ning,et al.  IL-17 contributes to autoimmune hepatitis , 2010, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[10]  Haiyang Xie,et al.  Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B , 2010, Journal of Clinical Immunology.

[11]  Zhi Chen,et al.  Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients , 2010, Journal of gastroenterology and hepatology.

[12]  B. Gao,et al.  Th17 cells and their associated cytokines in liver diseases , 2010, Cellular and Molecular Immunology.

[13]  Jiyuan Zhang,et al.  Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B , 2010, Hepatology.

[14]  Xin-Yuan Fu,et al.  Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. , 2009, Gastroenterology.

[15]  K. Tsuneyama,et al.  Halothane-induced liver injury is mediated by interleukin-17 in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[17]  J. Devière,et al.  The interleukin‐17 pathway is involved in human alcoholic liver disease , 2009, Hepatology.

[18]  C. Dong.  Regulation and pro‐inflammatory function of interleukin‐17 family cytokines , 2008, Immunological reviews.

[19]  J. Alcorn,et al.  Requirement of IL-17RA in Con A Induced Hepatitis and Negative Regulation of IL-17 Production in Mouse T Cells , 2008, The Journal of Immunology.

[20]  K. Mills,et al.  Hepatitis C Virus-Specific Th17 Cells Are Suppressed by Virus-Induced TGF-β1 , 2008, The Journal of Immunology.

[21]  Jay K Kolls,et al.  The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation , 2022 .

[22]  A. Murphy,et al.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. , 2007, Immunity.

[23]  Y. Takikawa,et al.  Interleukin‐17 as a new marker of severity of acute hepatic injury , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[24]  Q. Ning,et al.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. , 2003, The Journal of clinical investigation.

[25]  Ming Liu,et al.  Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. , 1998, Journal of immunology.

[26]  Yu-Chen Fan,et al.  Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B , 2009, Journal of Clinical Immunology.